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LETTERS TO THE EDITORPRICKLE2 Mutations Might
Not Be Involved in EpilepsyTo the Editor: Previously in The American Journal of
Human Genetics, Tao et al.1 performed a candidate-gene
analysis and reported that heterozygous mutations in
PRICKLE2 (MIM: 608501) are responsible for causing
seizures in several individuals with epilepsy (MIM:
613832). Here, by exome-wide mutation screening,
we found that compound-heterozygous mutations in a
well-established epilepsy- and ataxia-associated gene
are more likely to be the causal factor in one of the
individuals reported. Our results thus suggest that
PRICKLE2 mutations should presently not be considered
as causing epilepsy.
Tao et al. performed a mutation screen on a candidate
gene, PRICKLE2, on the basis of their earlier report linking
PRICKLE1 (MIM: 608500) mutations to epilepsy2 (MIM:
612437) and the sequence homology between PRICKLE1
and PRICKLE2. We exome sequenced several individuals
referred to us >10 years ago for having ‘‘atypical Unver-
richt Lundborg disease,’’ i.e., early-onset myoclonus
epilepsy with ataxia; samples and informed consent
were obtained in accordance with an institutional review
board. One sequenced individual has since been identified
by one of us as the sibling of patient 4 analyzed by Tao
et al., and both belong to a sibling relationship described
by Bird and Shaw in 1978.3 We think the mode of inher-
itance is more likely to be recessive than dominant with
incomplete penetrance, given that the two siblings were
affected at a young age and neither parent displayed
symptoms.3 In this individual, we identified the two
heterozygous PRICKLE2 mutations reported in his sib-
ling by Tao et al. and determined that they were on oppo-
site chromosomes. In addition, we identified three hetero-
zygous mutations in POLG (MIM: 174763; GenBank:
NM_002693.2): c.1399G>A (p.Ala467Thr), c.1491G>C
(p.Gln497His), and c.2243G>C (p.Trp748Ser). We con-
firmed these mutations also in his sibling, patient 4
from Tao et al. Two of these variants, p.Trp748Ser and
p.Ala467Thr, have been established as responsible for ep-
ilepsy and ataxia (MIM: 607459) in a recessive fashion in
numerous individuals.4–9 p.Gln497His has only been pub-
lished in tandem with p.Trp748Ser,9 suggesting co-occur-
rence on the same rare haplotype. We determined that
c.1399G>A and c.1491G>C were on opposite chromo-
somes, and we inferred from this rare haplotype that
one chromosome would possess the c.1399G>A mutation
and that the other chromosome would possess both
the c.1491G>C and c.2243G>C mutations. Importantly,
the symptoms reported for those carrying these POLG
mutations match those of the siblings, namely progressive588 The American Journal of Human Genetics 98, 588–589, March 3ataxia, myoclonus, sensory neuropathy, and epilepsy.
Given the >20 prior individuals with exactly the same
POLG mutations and with this specific set of pheno-
types,5,6 the POLG mutations are far more likely than
the postulated PRICKLE2 variants to have caused epilepsy
in this family.
Tao et al. discuss two other epilepsy-affected individ-
uals, patient 5 and patient 6, as potentially having a
heterozygous mutation and a heterozygous deletion in
PRICKLE2, respectively. Lacking DNA samples for these
two individuals, we could not ascertain whether exome-
wide variant screening might reveal that they too could
carry mutations in POLG or other more established epi-
lepsy-related genes. However, circumstantial evidence
can be obtained from large-scale variant databases. The
mutation reported in patient 5, c.1813G>T (p.Val605-
Phe), appears twice in the Exome Aggregation Con-
sortium (ExAC) Browser, which was not available at the
time of publication of Tao et al. ExAC reports variants
from over 60,000 individuals while excluding individuals
with severe pediatric diseases. It now contains more
than 800 carriers of missense mutations in PRICKLE2,
including four carriers of loss-of-function variants.
Although not definitive, this carrier rate seems inconsis-
tent with a gene with dominant mutations causing a pe-
diatric disorder.
In patient 6, Tao et al. proposed that a large heterozygous
deletion is responsible for epilepsy and autism. Other pa-
pers have confirmed that large heterozygous deletions,
including PRICKLE2, on chromosome 3 are associated
with autism,10 but nothing about epilepsy was mentioned
in that or other publications.
Tao et al. followed up on the mutations with zebrafish
assays, but these were not consistent, hence not conclu-
sive, because p.[Arg148His;Val153Ile] showed more
convergent-extension (CE) defects in zebrafish than the
wild-type, whereas p.Val605Phe showed fewer CE defects
than the wild-type. The mouse models presented for
PRICKLE2 demonstrate that knockout mice are more sus-
ceptible to seizures, but knockout models do not address
whether specific missense mutations are pathological
or not.
In summary, we present evidence that the reported
PRICKLE2 mutations in patient 4 are unlikely to cause ep-
ilepsy and identify POLG mutations that most likely
caused the symptoms. These results call into question the
other reported missense mutation proposed to implicate
PRICKLE2 in epilepsy. Our revised interpretation will
help avoid potential misdiagnosis or other associated ac-
tions, such as family-planning decisions, given that the
published mutations are often automatically considered
pathological because of their annotation in public muta-
tion databases for inherited diseases. Lastly, our experience
underscores the importance of continued re-interpretation, 2016
in a time of constantly improving technology, expanding
variant databases, and changing annotation.
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